We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-33.26%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.67B
AUM Growth
-$576M
Cap. Flow
+$898M
Cap. Flow %
33.65%
Top 10 Hldgs %
56.27%
Holding
114
New
27
Increased
37
Reduced
12
Closed
9

Top Buys

Rank Stock Value
1
RH icon
RH
RH
+$85.8M
2
W icon
Wayfair
W
+$72.3M
3
HCA icon
HCA Healthcare
HCA
+$41.4M
4
VG
Vonage Holdings Corporation
VG
+$35.2M
5
VAC icon
Marriott Vacations Worldwide
VAC
+$31.9M

Top Sells

Rank Stock Value
1
ARQL
Arqule Inc
ARQL
+$131M
2
ARYAU
ARYA Sciences Acquisiton Corp. Unit
ARYAU
+$5.21M
3
QADA
QAD Inc.
QADA
+$3.64M
4
EVRI
Everi Holdings
EVRI
+$3.36M
5
ELVT
Elevate Credit, Inc.
ELVT
+$2.15M

Sector Composition

Rank Sector Weight
1 Healthcare 17%
2 Consumer Discretionary 10.32%
3 Industrials 5.14%
4 Technology 4.37%
5 Financials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZVO
76
DELISTED
Zovio Inc. Common Stock
ZVO
$4.38M 0.16%
2,653,087
– –
STR
77
DELISTED
Sitio Royalties
STR
$4.18M 0.16%
486,036
– –
VIRX
78
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.97M 0.15%
273,338
+22,892
+9% +$497K
PENN icon
79
PUT
PENN Entertainment
PENN
$2.57B
$3.79M 0.14%
+300,000
New +$7.54M
APEN
80
DELISTED
Apollo Endosurgery, Inc.
APEN
$3.55M 0.13%
1,848,672
+38,110
+2% +$100K
NEOS
81
DELISTED
Neos Therapeutics, Inc
NEOS
$3.46M 0.13%
4,610,000
– –
FBIO icon
82
Fortress Biotech
FBIO
$86.7M
$3.46M 0.13%
121,920
+94,773
+349% +$3.15M
TA
83
DELISTED
TravelCenters of America LLC
TA
$3.3M 0.12%
337,390
– –
PRTY
84
DELISTED
Party City Holdco Inc.
PRTY
$3.27M 0.12%
7,133,136
-532,638
-7% -$1.09M
SSKN
85
DELISTED
Strata Skin Sciences
SSKN
$3.09M 0.12%
325,100
+40,000
+14% +$660K
OTRK
86
DELISTED
Ontrak
OTRK
$2.99M 0.11%
+2,179
New +$3.03M
STRM
87
DELISTED
Streamline Health Solutions
STRM
$2.34M 0.09%
183,573
– –
CZR
88
CALL
DELISTED
Caesars Entertainment Corporation
CZR
$2.24M 0.08%
331,000
-3,000,000
-90% -$35.3M
AFI
89
DELISTED
Armstrong Flooring, Inc.
AFI
$2.23M 0.08%
1,556,435
+26,330
+2% +$81.5K
TFFP
90
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$2.22M 0.08%
23,169
+2,169
+10% +$258K
DMAC icon
91
DiaMedica Therapeutics
DMAC
$370M
$2.14M 0.08%
+750,000
New +$3.1M
DVD
92
DELISTED
Dover Motorsports
DVD
$2.12M 0.08%
1,695,541
– –
ACER
93
DELISTED
Acer Therapeutics Inc
ACER
$1.97M 0.07%
990,655
– –
HTGM
94
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1.65M 0.06%
28,112
+334
+1% +$32.7K
MACK
95
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.61M 0.06%
747,635
– –
NNI icon
96
Nelnet
NNI
$4.48B
$1.58M 0.06%
+34,900
New +$1.88M
EMMS
97
DELISTED
Emmis Communications Corp
EMMS
$1.56M 0.06%
781,783
-50,034
-6% -$168K
DRIO icon
98
DarioHealth
DRIO
$74.8M
$1.45M 0.05%
10,705
– –
AGS
99
DELISTED
PlayAGS
AGS
$1.1M 0.04%
+413,804
New +$3.41M
EBIX
100
DELISTED
Ebix Inc
EBIX
$1.02M 0.04%
+66,997
New +$1.91M
1 2 3
4
5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return

Nantahala Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Nantahala Capital Management held 114 positions worth $2.67B, down 18% from $3.25B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management deployed $898M of net new capital in Q1 2020, opening 27 new positions and adding to 37 existing holdings. Its largest new stake was HCA Healthcare: 319,434 shares worth $28.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was QAD Inc., an estimated $3.64M trimmed.

  • Nantahala Capital Management's largest Q1 2020 buy was HCA Healthcare: 319,434 shares worth $28.7M.
  • Nantahala Capital Management added most to RH in Q1 2020, an estimated $85.8M increase.
  • Nantahala Capital Management's biggest Q1 2020 reduction was QAD Inc., cutting an estimated $3.64M.
  • Nantahala Capital Management fully exited Arqule Inc in Q1 2020, selling an estimated $131M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $2.67B portfolio in Q1 2020.
  • Nantahala Capital Management opened 27 new positions and closed 9 in Q1 2020.
  • Nantahala Capital Management's portfolio value fell 18% quarter-over-quarter to $2.67B.

Based on Nantahala Capital Management's 13F filing for Q1 2020, filed 14 May 2020.